Locoregional Therapies of Cholangiocarcinoma.

ABSTRACT:

Background

Cholangiocarcinoma (CC) is the second most primary liver malignancy with increasing incidence in Western countries. Currently, surgical R0 resection is regarded as the only potentially curative treatment. The results of systemic chemotherapy and best supportive care (BSC) in patients with metastatic disease are often disappointing in regard to toxicity, oncologic efficacy, and overall survival. In current practice, the use of different locoregional therapies is increasingly more accepted.

Methods

A review of the literature on locoregional therapies for intrahepatic cholangiocarcinoma (ICC) was undertaken.

Results

There are no prospective randomized controlled trials. For localized ICC, either primary or recurrent, radiofrequency ablation (RFA) is by far the

SUBMITTER: Sommer CM 

PROVIDER: S-EPMC5290439 | biostudies-literature | 2016 Dec

REPOSITORIES: biostudies-literature